InvestorsHub Logo
Followers 21
Posts 1234
Boards Moderated 0
Alias Born 12/10/2010

Re: None

Friday, 03/14/2014 9:11:11 PM

Friday, March 14, 2014 9:11:11 PM

Post# of 699699
Farzin Farzaneh, Professor of Molecular Medicine and head of cGMP cell product manufacturing at King’s College London, said: 'We are excited to be undertaking the manufacture of the vaccine here at King’s. Such immune therapies represent an exciting new class of products, and we are pleased to apply our expertise and facilities for cell therapy to help bring DCVax® immune therapies to the UK and to collaborating centres in Europe.' http://www.kcl.ac.uk/newsevents/news/newsrecords/2012/05May/Brain-Cancer-Vaccine.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News